A Potential Drug Target for Chromosome 22 Open Reading Frame 24 (YWHAH-AS1)

Target Name: YWHAH-AS1

NCBI ID: G25775

YWHAH-AS1

A Potential Drug Target for Chromosome 22 Open Reading Frame 24 (YWHAH-AS1)

Introduction

Chromosome 22 is a key regulator of cell division and growth, and its open reading frame (ORF) 24 is a gene that has been extensively studied for its role in various cellular processes. ORF 24 is a transcribed gene that contains 219 amino acid residues and is located on the long arm of chromosome 22. In recent years, researchers have identified several potential drug targets in ORF 24, including the gene for the Y-linked RNA-protein convertase (YWHAH) gene.

The Y-linked RNA-protein convertase (YWHAH) gene is a non-coding RNA molecule that plays a critical role in the regulation of gene expression and translation in the male germ line. It is expressed in testes, and its absence or mutations have has been linked to various developmental and reproductive problems, including infertility, gonorrhea, and psychosis.

Recent studies have suggested that ORF 24 may be a drug target for YWHAH-AS1, a gene that encodes a protein known as YWHAH-AS1. YWHAH-AS1 is a 21-kDa protein that is expressed in various tissues and cells, including testes, germ cells, and tissues derived from the nervous system. It is involved in the regulation of cellular processes, including cell adhesion, migration, and survival.

Several studies have demonstrated that YWHAH-AS1 plays a critical role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that YWHAH-AS1 is involved in the regulation of cell proliferation and survival in cancer cells, and that it is a potential therapeutic target for cancer treatment.

In addition to its potential therapeutic applications, YWHAH-AS1 is also a potential biomarker for cancer and other diseases. Its expression has been detected in various types of cancer, including breast, ovarian, and prostate cancer, and its levels have been shown to be elevated in individuals with cancer. This suggests that YWHAH-AS1 may be a useful biomarker for cancer diagnosis and treatment.

The YWHAH-AS1 gene is located on the long arm of chromosome 22, and its ORF 24 gene has been extensively studied for its potential role in various cellular processes. Several studies have demonstrated that ORF 24 is involved in the regulation of cellular processes, including cell adhesion, migration, and survival.

In addition to its role in cellular processes, ORF 24 has also been shown to play a critical role in the regulation of gene expression and translation in the male germ line. It is expressed in testes and its absence or mutations have been linked to various developmental and reproductive problems, including infertility, gonorrhea, and psychosis.

Recent studies have suggested that ORF 24 may be a potential drug target for YWHAH-AS1, a gene that encodes a protein known as YWHAH-AS1. YWHAH-AS1 is a 21-kDa protein that is expressed in various tissues and cells, including testes , germ cells, and tissues derived from the nervous system. It is involved in the regulation of cellular processes, including cell adhesion, migration, and survival.

Several studies have demonstrated that YWHAH-AS1 plays a critical role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that YWHAH-AS1 is involved in the regulation of cell proliferation and survival in cancer cells, and that it is a potential therapeutic target for cancer treatment.

In addition to its potential therapeutic applications, YWHAH-AS1 is also a potential biomarker for cancer and other diseases. Its expression has been detected in various types of cancer, including breast, ovarian, and prostate cancer, and its levels have been shown to be elevated in individuals with cancer. This suggests that YWHAH-AS1 may be

Protein Name: YWHAH Antisense RNA 1

The "YWHAH-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about YWHAH-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets